AIM-Bio Biopharmaceutical Symposium aims to strengthen DTU–NC State partnership

The AIM-Bio Steering Committee invites you to attend the fourth annual AIM-Bio Biopharmaceutical Manufacturing Symposium, which will be held at the Technical University of Denmark (DTU) on Monday, Oct. 30 and at the Biotech City of Kalundborg on Tuesday, Oct. 31, 2023, located approximately 100 km from DTU.

The symposium aims to foster knowledge exchange and strengthen our scientific partnership. We are expecting to identify additional synergies between North Carolina and Denmark across the value chain anchored to AIM-Bio program.

We look forward to bringing together researchers, scientists, and industry experts from both sides of the Atlantic to share their latest discoveries and insights. The symposium will feature engaging keynote presentations, oral presentations, and a poster session — all expected to facilitate fruitful discussions and networking opportunities. 

The program at DTU includes two keynote speakers from industry:

  • Dr. Mark Duerkop, CEO Novasign GmbH, Vienna, Austria. He will present “Hybrid Modeling: a strong basis for accelerated process development and automated process control.” 

  • Dr. David Pollard, Head of Advanced BioProcessing, Sartorius Corporate Research, Cambridge, Massachusetts, U.S., who will present “Enabling New Therapeutic Modalities & Platforms.”  

AIM-Bio researchers will present the expected and realized translational outcomes within the research areas of cell line development and metabolics, process analytical technologies – modeling and control, and single-use downstream technologies. 

In addition, the experiences, initiatives, and vision for the BTEC and DTU AIM-Bio lifelong learning courses will be presented.

DTU Chemical and Biochemical Engineering, building 228A (photo: MT Kommunikation)
DTU Chemical and Biochemical Engineering, building 228A (photo: MT Kommunikation)

On Tuesday, Oct. 31, the program at the Biotech City of Kalundborg will include presentations by the following companies:

In addition, industry tours at Novo Nordisk, Helix Lab, Novozymes, and Kalundborg Forsyning will take place in the afternoon. The day will also include a poster session on AIM-Bio research and lifelong learning courses.  

The Biotech City of Kalundborg is based on a unique partnership where local companies, educational institutions, and public organizations collaborate to support and strengthen Kalundborg’s industry, educational opportunities, and the green agenda.

Contact Eva Mikkelsen ( at DTU or Delia Bradley ( at NC State University with any questions.

About AIM-Bio
Funded by the Novo Nordisk Foundation, the AIM-Bio program brings together two academic universities, the Technical University of Denmark (DTU) and North Carolina State University, to create an international collaboration to drive innovation in research and education in manufacturing biopharmaceuticals.